David A. Andry | Senior Director National Accounts
David A. Andry, OTR/L graduated from Florida International University in 1993 with his Bachelor’s Degree in Occupational Therapy. Since 1993, David has worked as an occupational therapist in various areas including in-patient and out-patient rehab, long term care, acute care settings, home health and wound care. In addition, throughout his career as an occupational therapist, he has always worked in pediatrics as well and has specialized in this area. He continues to devote his time to working with children on weekends.
David has also worked in extensively in the pharmaceutical arena from sourcing products, product development, and unit dose solutions for hospitals via in-house repackaging and sales.
David brings his vast clinical knowledge and sales edge to provide quality, customer oriented service; not only to his customers, but also the patients, pharmacies, and physicians they serve.
Companies Worked For:
- Parkway Regional Medical Center-Miami, Fl
- Mercy Hospital-Miami, Fl
- Hearing and Speech Center of Florida-Miami, Fl
- Theracare Home Health-Miami, Fl
- Quali-Care Home Health-Miami, Fl
- Florida Homebound, Miami, Fl
- Handwriting Without Tears, Cabin John, MD-Based in Miami
- Abilities in Motion-Miami, Fl Owner private therapy company servicing schools in migrant farmworkers communities and homebound children.
- AHP Group, Miami, Fl
- Gensco Pharma, Miami, Fl-Based in Las Vegas, NV
Gensco Executive Team
Paul Zimmerman, M.D. | Chairman & CEO bio »
Frank Aguilar | VP, National Accounts
Crystal Lore | VP, Business Development bio »
Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs bio »
David A. Andry | Senior Director National Accounts
Lewis Archibeck | Sr. Sales Executive
Lisa Capote, Esq | General Counsel
GENSCO® TRENDING
- Gensco® Pharma Announces RizaFilm® Commercialization Update in the United States September 26, 2023 Featured, Industry, Press Release, Product Update - Gensco® Pharma, a specialty pharmaceutical company, in partnership with IntelGenx is announcing the anticipated launch… more...
- Skin Tears Treatment Market to Observe Strong Development by 2018-2026 April 15, 2019 Articles, Featured, Industry - [To download a printable version of this article, click here] MARKET RESEARCH April 12, 2019… more...
- Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAFILM® (U.S. market name for RIZAPORT® — Rizatriptin Oral Film) in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in… more...
- AAP Issues Flu Vaccine Recommendations for 2018-2019 September 6, 2018 Articles, Industry - All children should receive the flu shot as soon as it is available: AAP [To… more...